SHANDONG BOAN BIOTECH.H 1 (UJ9) — Capital Reinvestment Ratio
Latest as of December 2025:
4.22x
SHANDONG BOAN BIOTECH.H 1 (UJ9) has a Capital Reinvestment Ratio of 4.22x as of December 2025, meaning it reinvests 4% of its operating cash flow (€64.89 Million) in capital expenditures (€274.05 Million). See UJ9 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
4.22x
Capex / Operating Cash Flow
Operating Cash Flow
€64.89 Million
EUR
Capital Expenditures
€274.05 Million
EUR
Data as of
Dec 2025
Most recent filing
SHANDONG BOAN BIOTECH.H 1 Capital Reinvestment Ratio (2025–2025)
This chart tracks SHANDONG BOAN BIOTECH.H 1's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for SHANDONG BOAN BIOTECH.H 1 (2025–2025)
Year-by-year Capital Reinvestment Ratio for SHANDONG BOAN BIOTECH.H 1 from 2025 to 2025. For live market cap and broader valuation context, see SHANDONG BOAN BIOTECH.H 1 market capitalisation.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 4.22x | €64.89 Million | €274.05 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow